105
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

, , , , , , & show all
Pages 151-162 | Published online: 11 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Winghan J Kwong, Syed Numan, Tina D Hunter, Dalila Alves, Anish Patel & Satish Shanbhag. (2023) Patient-Reported Outcomes After Ferric Carboxymaltose Treatment for Iron Deficiency Anemia: A Prospective Observational Study. International Journal of General Medicine 16, pages 3291-3300.
Read now
N Franklin Adkinson, William E Strauss, Kristine Bernard, Robert F Kaper, Iain C Macdougall & Julie S Krop. (2017) Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions. Journal of Blood Medicine 8, pages 155-163.
Read now

Articles from other publishers (8)

Brigitta Teutsch, Szilárd Váncsa, Nelli Farkas, Zsolt Szakács, Nóra Vörhendi, Eszter Boros, Imre Szabó, Roland Hágendorn, Hussain Alizadeh, Péter Hegyi & Bálint Erőss. (2023) Intravenous f err i c carboxymaltos e ve r sus oral ferrous sulfate repla ce ment in elderly patients after acute non-variceal gastrointestinal bleeding ( FIERCE ): protocol of a multicentre, open-label, randomised controlled trial . BMJ Open 13:3, pages e063554.
Crossref
Laura A. Maas, Mahesh Krishna & Alyssa M. Parian. (2022) Ironing It All Out: A Comprehensive Review of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences 68:2, pages 357-369.
Crossref
Giovanna Culeddu, Li Su, Yafeng Cheng, Dora I. A. Pereira, Rupert A. Payne, Jonathan J. Powell & Dyfrig A. Hughes. (2021) Novel oral iron therapy for iron deficiency anaemia: How to value safety in a new drug?. British Journal of Clinical Pharmacology 88:3, pages 1347-1357.
Crossref
Dawn Farrell, Micol Artom, Wladyslawa Czuber-Dochan, Lars P Jelsness-Jørgensen, Christine Norton & Eileen Savage. (2020) Interventions for fatigue in inflammatory bowel disease. Cochrane Database of Systematic Reviews 2020:4.
Crossref
Birgit Ehlken, Lennart Nathell, Annegret Gohlke, Derya Bocuk, Massoud Toussi & Stefan Wohlfeil. (2018) Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017. Drug Safety 42:3, pages 463-471.
Crossref
Yanping Shao, Wenda Luo, Haiyan Xu, Li Zhang & Qunyi Guo. (2019) The Efficacy of Ferumoxytol for Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials. Acta Haematologica 142:3, pages 125-131.
Crossref
Ole Nielsen, Christoffer Soendergaard, Malene Vikner & Günter Weiss. (2018) Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease. Nutrients 10:1, pages 82.
Crossref
Jinxia Li, Feng Zhao & Chunying Chen. (2016) The new face of iron oxide nanoparticles: the bullets targeting tumor microenvironment for cancer therapy. Science Bulletin 61:23, pages 1788-1790.
Crossref